The “anti Covid pill” within a year

The White House has allocated $ 3.2 billion (initial) to research an effective antiviral against Sars-Cov2. In practice, one “Anticovid pill”, which according to the hopes of the United States could also arrive by the end of the year. «We want to accelerate works that are already underway – said Anthony Fauci announcing the allocation of funds.

The project is ambitious. An effective antiviral pill – to date, over 200 drugs are being studied – would render the virus harmless by limiting its spread, and would exceed the limits of the vaccine: the lower efficacy against the variants, the lower protection for some subjects (immunosuppressed), and the psychological aspect, which means that a part of the population does not choose to protect themselves with vaccination.

The use of a pill, on the other hand, is much simpler, to be taken at home when the first symptoms are felt and capable of inhibiting the replication mechanisms of the virus thus preventing the inflammatory reaction of the body. And if said so it seems a chimera, in reality one of these drugs, the molnupiravir of the American pharmaceutical company Merk-Msd has reached phase three of the trial (the last).

You may also like